Sagara Y. .2015 .Survival benefit of breast surgery for lowgrade ductal carcinoma in situ: A population-based cohort study. ” JAMA Surgery, 150 : 739-745.
Grimm L.J. .2022 .Ductal carcinoma in situ: State-of-the-art review. ” Radiology, 302 : 246-255.
Ernster V.L. .2002 .Detection of ductal carcinoma in situ in women undergoing screening mammography. ” Journal of the National Cancer Institute, 94 : 1546-1554.
Kuerer H.M. . .DCIS margins and breast conservation: MD Anderson cancer center multidisciplinary practice guidelines and outcomes. ” Journal of Cancer, 8(2017) : 2653-2662.
Wadsten C. .2016 .A Validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 Years. Acta Oncologica, 55 : 1338-1343.
Bosaeed K.M. . .Cross-sectional descriptive study on the epidemiology of operated female breast tumor cases in a tertiary Hospital of Saudi Arabia. Saudi Surgical Journal, 6(2018) : 71-74.
Albasri A. .2014 .Histopathological features of breast cancer in Al-Madinah Region of Saudi Arabia. Saudi Medical Journal, 35 : 1489-1493.
Alnefaie S.M. .2024 .Incidence and characteristics of breast cancer in patients 40 years of age or younger. International Surgery Journal, 11 : 335-338.
Sopik V. .2018 .Impact of Microinvasion on breast cancer mortality in women with ductal carcinoma in Situ. Breast Cancer Research and Treatment, 167 : 787-795.
Giannakeas V. .2018 .A comparison of two models for breast cancer mortality for women with ductal Carcinoma in Situ. Breast Cancer Research and Treatment, 169 : 587-594.
Hanna W.M. .2019 .Ductal carcinoma in situ of the breast: an update for the pathologist. ” Modern Pathology, 32 : 896-915.
van Seijen M. .2019 .Ductal carcinoma in situ: To treat or not to treat, that is the question. British Journal of Cancer, 121 : 285-292.
Hagio K. .2021 .Genetic heterogeneity during breast cancer progression in young patients.” The Breast. , 60 : 206-213.
van der Borden C.L. . .Avoiding overtreatment of ductal carcinoma in situ. ” Trends in Cancer, 5(2019) : 391-393.
Casasent A.K. .2017 .Genome Evolution in ductal carcinoma in situ: invasion of the clones. ” Journal of Pathology, 241 : 208-218.
Sakr R.A. .2014 .PI3K Pathway activation in high-grade ductal carcinoma in situ. ” Clinical Cancer Research, 20 : 2326-2337.
Pareja F. .2020 .Whole-exome sequencing analysis of the progression from non-low-grade ductal carcinoma in situ to invasive ductal carcinoma. ” Clinical Cancer Research, 26 : 3682-3693.
Gibson S.V. . .Everybody needs good neighbours: the progressive DCIS microenvironment. ” Trends in Cancer, 9(2023) : 326-338.
Ponti A. .2019 .Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions. ” Breast Cancer Research and Treatment, 177 : 761-765.
Zhao M.R. .2023 .Feasibility analysis of MRI-based radiomics for preoperative prediction of nuclear grading of DCIS.” Gland Surgery. , 12 : 1209-1223.
Cutuli B. .2020 .Ductal Carcinoma in situ: A French national survey. ” Clinical Breast Cancer, 20 : e164-e172.
Alaeikhanehshir S. .2024 .Effects of contemporary treatment of DCIS on the risk of ipsilateral invasive breast cancer. ” Breast Cancer Research and Treatment, 204 : 61-68.
Shaaban A.M. .2021 .Pathological features of 11,337 patients with primary DCIS. British Journal of Cancer, 124 : 1009-1017.
Goh C.W. .2019 .. “IDC/DCIS versus Pure IDC.” Journal of Cancer Research and Clinical Oncology, 145 : 1877-1886.
Song G.,Y. Zhang. G. . .Breast DCIS with microinvasion. ” Chronic Diseases and Translational Medicine, 9(2023) : 5-13.
Doebar S.C. .2016 .Extent of DCIS according to breast cancer subtypes. ” Breast Cancer Research and Treatment, 158 : 179-187.
Al-Ameer A.Y. . .Sentinel lymph node biopsy in clinically detected DCIS. World Journal of Clinical Oncology, 7(2016) : 258-264.
Groen E.J. .2020 .Prognostic value of histopathological DCIS Features. Breast Cancer Research and Treatment, 183 : 759-770.
Pinder S.E. .2010 .A New pathological system for grading DCIS. British Journal of Cancer, 103 : 94-100.
Badve S.S.,Gökmen-Polar Y. .2019 .. Ductal carcinoma in situ of breast: Update 2019.” Pathology, 51 : 563-569.
Wang J. . .Progression from DCIS to invasive breast cancer. ” Signal Transduction and Targeted Therapy, 9(2024) : 83.
Schandiz H. .2023 .Subtypes of high-grade DCIS. Breast Cancer Research and Treatment, 201 : 329-338.
Howard-McNatt M. .2021 .Impact of cavity shave margins in DCIS.” Journal of the American College of Surgeons. , 232 : 373-378.
Kunkiel M.,A M. .2021 .. Van Nuys prognostic index in DCIS.” Scientific Reports, 11 : 22645.
Sigal-Zafrani B. .2004 .Histological margin assessment for DCIS.” Modern Pathology. , 17 : 81-88.
Hwang E.S. .2024 .Active monitoring for low-risk DCIS: The COMET Trial. ” JAMA, 333 : 972-980.
Elshof L.E. .2015 .. The LORD Study.” European Journal of Cancer, 51 : 1497-1510.
Francis A. .2015 .. The LORIS Trial.” European Journal of Cancer, 51 : 2296-2303.
Kanbayashi C. .2019 .International collaboration of active surveillance trials for low-risk DCIS. ” Journal of Clinical Oncology, 37(suppl) : .